Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study) (ITCHY)
Sponsor: Burnet Institute
This PHASE2 trial investigates Scabies and Scabies; Itch and is currently actively recruiting participants. Burnet Institute leads this study, which shows 14 recorded versions since 2025 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE2
-
Aug 2025 — Sep 2025 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jul 2025 — Aug 2025 [monthly]
Not Yet Recruiting PHASE2
-
Mar 2025 — Jul 2025 [monthly]
Not Yet Recruiting PHASE2
-
Oct 2024 — Mar 2025 [monthly]
Not Yet Recruiting PHASE2
▶ Show 9 earlier versions
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE2
-
May 2024 — Jul 2024 [monthly]
Not Yet Recruiting PHASE2
Status: Active Not Recruiting → Not Yet Recruiting
-
Dec 2023 — May 2024 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Aug 2023 — Dec 2023 [monthly]
Recruiting PHASE2
Phase: PHASE4 → PHASE2
-
Jul 2023 — Aug 2023 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Apr 2023 — Jul 2023 [monthly]
Not Yet Recruiting PHASE4
-
Dec 2022 — Apr 2023 [monthly]
Not Yet Recruiting PHASE4
-
Sep 2022 — Dec 2022 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Burnet Institute
- Lao Tropical and Public Health Institute
- Murdoch Childrens Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .